메뉴 건너뛰기
Cancer
Volumn 113, Issue 6, 2008, Pages 1282-1283
Is patient performance status always an accurate surrogate for predicting tumor biology in patients with metastatic renal cancer?
Author keywords

[No Author keywords available]
Indexed keywords

ACCURACY; ARTIFICIAL EMBOLISM; BIOLOGY; BONE METASTASIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; KIDNEY CANCER; LOG RANK TEST; NEPHRECTOMY; ONCOLOGY; OUTCOME ASSESSMENT; PERFORMANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;
EID: 53149084487     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23709     Document Type: Editorial
Times cited : (2)
References (7)
  • 1
    • 0020396015 scopus 로고
    • Toxicity and response criteria of the Eastern Cooperative Oncology Group
    • Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
    • (1982) Am J Clin Oncol , vol.5 , pp. 649-655
    • Oken, M.M.1    Creech, R.H.2    Tormey, D.C.3
  • 2
    • 0032772880 scopus 로고    scopus 로고
    • Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
    • Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17:2530-2540.
    • (1999) J Clin Oncol , vol.17 , pp. 2530-2540
    • Motzer, R.J.1    Mazumdar, M.2    Bacik, J.3    Berg, W.4    Amsterdam, A.5    Ferrara, J.6
  • 3
    • 0034071278 scopus 로고    scopus 로고
    • Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria
    • quiz 1295
    • Tsui KH, Shvarts O, Smith RB, Figlin RA, deKemion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 2000;163:1090-1095; quiz 1295.
    • (2000) J Urol , vol.163 , pp. 1090-1095
    • Tsui, K.H.1    Shvarts, O.2    Smith, R.B.3    Figlin, R.A.4    deKemion, J.B.5    Belldegrun, A.6
  • 4
    • 0035868654 scopus 로고    scopus 로고
    • Improved prognostication of renal cell carcinoma using an integrated staging system
    • Zisman A, Pantuck AJ, Dorey F, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol. 2001;19:1649-1657.
    • (2001) J Clin Oncol , vol.19 , pp. 1649-1657
    • Zisman, A.1    Pantuck, A.J.2    Dorey, F.3
  • 5
    • 0030873895 scopus 로고    scopus 로고
    • Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma
    • Fallick ML, McDermott DF, LaRock D, Long JP, Atkins MB. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol. 1997;158:1691-1695.
    • (1997) J Urol , vol.158 , pp. 1691-1695
    • Fallick, M.L.1    McDermott, D.F.2    LaRock, D.3    Long, J.P.4    Atkins, M.B.5
  • 7
    • 53149147043 scopus 로고    scopus 로고
    • Performance status and cytoreductive nephrectomy: Redefining management in patients with poor performance
    • Shuch B, LaRochelle JC, Wu J, et al. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance. Cancer. 2008:113:1324-1331.
    • (2008) Cancer , vol.113 , pp. 1324-1331
    • Shuch, B.1    LaRochelle, J.C.2    Wu, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.